FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36627311000001101: Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Mar 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
155981000001119 Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
155991000001117 Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Is a Lumacaftor 100mg / Ivacaftor 125mg tablets 112 tablet true Inferred relationship Existential restriction modifier
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has AMP Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) true Inferred relationship Existential restriction modifier
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has specific active ingredient Ivacaftor true Inferred relationship Existential restriction modifier
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has specific active ingredient Lumacaftor true Inferred relationship Existential restriction modifier
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Orkambi 100mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start